Clinical Trials List
Protocol NumberGF-01-01
Active
2025-05-01 - 2027-12-31
Phase I
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 李思慧 Division of General Internal Medicine
- YAO CHI-YUAN Division of Others -
- 徐思淳 Division of Others
- Tai-Chung Huang Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
- Wen-Chien Chou Division of Others -
- 施怡倫 Division of Radiology
- 袁章祖 Division of Others
- Huai-Hsuan Huang Division of General Internal Medicine
- 范淞斌 Division of Neurology
- MING YAO Division of General Internal Medicine
- - - Division of Hematology & Oncology
- Ming-Che Kuo Division of General Internal Medicine
- CHENG-HONG TSAI Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- HSIN-AN HOU Division of General Internal Medicine
- 柯紀綸 Division of Nuclear Medicine
- WEI-LI MA Division of Hematology & Oncology
- 劉高郎 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
0 participants
